Antihypertensive drugs do not qualify as optimal candidates for therapeutic drug monitoring
(TDM), given their obvious physiological effect, the absence of a clear relationship between …

Adherence to antihypertensive therapy is critical to achieving adequate blood pressure
control. About half of hypertensive patients do not take their drugs as directed and the …

Aims Arterial hypertension is an important cardiovascular risk factor. A substantial proportion
of patients show resistance to antihypertensive treatment but poor adherence to medication …

Poor adherence (compliance) to antihypertensive medications is a major contributor to
morbidity and mortality in patients with hypertension. Estimates in the literature of the extent …

The quality of assessment of non-adherence to treatment in hypertensive is poor. Within this
review, we discuss the different methods used to assess adherence to blood-pressure …

258 Hypertension August 2017 other than hypertension,(2) BP measurements in this setting
do not reflect the ambulatory BP profiles of these patients,(3) information about the precise …

Background Adherence to antihypertensive drugs (AHDs) is important for adequate blood
pressure control. Not taking these drugs as prescribed is one of the main underlying causes …

Background: Therapeutic drug monitoring (TDM) involves the measurement of serum drug
concentrations to optimize pharmacotherapy. Traditionally, blood pressure measurements …

BACKGROUND Drug concentration in blood or urine is an acknowledged method to detect
non-adherence. Observational studies suggest that informing patients about low or absent …

Biochemical drug screening by liquid chromatography-tandem mass spectrometry in plasma
is an accurate method for the quantification of plasma concentrations of antihypertensive …